# Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca

> **NCT00944424** · PHASE3 · UNKNOWN · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 260 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Docetaxel + High dose Vitamin D2
- **DRUG:** Docetaxel + Standard dose Vitamin D2

## Key facts

- **NCT ID:** NCT00944424
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2011-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944424, "Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00944424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*